HGVSc	SYMBOL	Consequence	clinvar_clnsig	clinvar_golden_stars	clinvar_rs	clinvar_trait	ClinVar	ClinVar_ALLELEID	ClinVar_CLNDN	ClinVar_CLNDNINCL	ClinVar_CLNDISDB	ClinVar_CLNDISDBINCL	ClinVar_CLNHGVS	ClinVar_CLNREVSTAT	ClinVar_CLNSIG	ClinVar_CLNSIGCONF	ClinVar_CLNSIGINCL	ClinVar_CLNVC	ClinVar_CLNVCSO	ClinVar_CLNVI	ClinVar_DBVARID	ClinVar_GENEINFO	ClinVar_MC	ClinVar_ORIGIN	ClinVar_RS	ClinVar_SSR	ClinVar_CLNSUBA	ClinVar_CLNSIGA	ClinVar_CLNDATEA	ClinVar_CLNDATESUBA	ClinVar_CLNREVSTATA	ClinVar_CLNORA	ClinVar_CLNSCVA	ClinVar_CLNDNA	ClinVar_CLNCOMA	case_id
NM_007194.3:c.1283C>T	CHEK2	missense_variant	5&5&5&5	2&1&1&1	rs137853011	Hereditary cancer-predisposing syndrome&Familial cancer of breast&Breast and colorectal cancer, susceptibility to&not provided	5603	20642	Osteosarcoma|Malignant_tumor_of_prostate|Neoplasm_of_the_breast|Hereditary_breast_and_ovarian_cancer_syndrome|Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|Colorectal_cancer|Li-Fraumeni_syndrome_2|Breast_and_colorectal_cancer,_susceptibility_to|Breast_cancer,_susceptibility_to|CHEK2-Related_Cancer_Susceptibility|not_provided	-	Human_Phenotype_Ontology:HP:0002669,MeSH:D012516,MedGen:C0029463,OMIM:259500,Orphanet:ORPHA668,SNOMED_CT:21708004|Human_Phenotype_Ontology:HP:0012125,MedGen:C0376358,OMIM:176807,SNOMED_CT:399068003|Human_Phenotype_Ontology:HP:0100013,MeSH:D001943,MedGen:C1458155,Orphanet:ORPHA180250,SNOMED_CT:126926005|MeSH:D061325,MedGen:C0677776,Orphanet:ORPHA145|MedGen:C0006142,OMIM:114480,Orphanet:ORPHA227535,SNOMED_CT:254843006|MedGen:C0027672,SNOMED_CT:699346009|MedGen:C1527249|MedGen:C1836482,OMIM:609265|MedGen:C1858433|MedGen:C3469522|MedGen:CN239278|MedGen:CN517202	-	NC_000022.10:g.29091207G>A	_conflicting_interpretations	Conflicting_interpretations_of_pathogenicity	Likely_pathogenic(5),Pathogenic(11),Uncertain_significance(1)	-	single_nucleotide_variant	SO:0001483	Illumina:203534|Quest_Diagnostics_Nichols_Institute_San_Juan_Capistrano:2833351|OMIM_Allelic_Variant:604373.0014|UniProtKB_(protein):O96017#VAR_022463	-	CHEK2:11200	SO:0001583|missense_variant	1	137853011	-	OMIM|Genetic_Services_Laboratory,_University_of_Chicago|Ambry_Genetics|Color|GeneKor_MSA|Invitae|Counsyl|Mendelics|Human_Genome_Sequencing_Center_Clinical_Lab,Baylor_College_of_Medicine|University_of_Washington_Department_of_Laboratory_Medicine,_University_of_Washington|GeneDx|Quest_Diagnostics_Nichols_Institute_San_Juan_Capistrano|CeGaT_Praxis_fuer_Humangenetik_Tuebingen|Illumina_Clinical_Services_Laboratory,Illumina|Illumina_Clinical_Services_Laboratory,Illumina|Fulgent_Genetics,Fulgent_Genetics|Integrated_Genetics/Laboratory_Corporation_of_America|Illumina_Clinical_Services_Laboratory,Illumina	risk_factor|Pathogenic|Pathogenic|Pathogenic|Likely_pathogenic|Pathogenic|Likely_pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Likely_pathogenic|Likely_pathogenic|Uncertain_significance|Pathogenic|Pathogenic|Likely_pathogenic|Pathogenic	2005-02-15|2017-02-21|2019-10-30|2015-02-16|2018-08-01|2019-01-08|2017-05-22|2018-07-02|2017-06-05|2015-11-20|2019-01-02|2019-03-22|2018-06-01|2016-06-14|2016-06-14|2017-05-18|2019-01-15|2017-09-05	2017-11-21|2017-07-05|2020-02-26|2016-07-05|2018-08-08|2019-03-28|2017-06-22|2018-08-20|2018-06-14|2016-03-03|2019-01-29|2020-03-06|2019-07-12|2016-10-18|2016-10-18|2017-05-23|2019-09-24|2019-02-01	no_assertion_criteria_provided|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter	germline|germline|germline|germline|germline|germline|unknown|unknown|germline|germline|germline|germline|germline|germline|germline|unknown|germline|germline	SCV000026135|SCV000594114|SCV000187227|SCV000292126|SCV000821728|SCV000253983|SCV000677740|SCV000839461|SCV000839938|SCV000266068|SCV000149903|SCV000601148|SCV000892318|SCV000437716|SCV000437715|SCV000611259|SCV000698769|SCV000914987	Breast_cancer,_susceptibility_to|Breast_cancer,_susceptibility_to|Hereditary_cancer-predisposing_syndrome|Hereditary_cancer-predisposing_syndrome|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Familial_cancer_of_breast|Familial_cancer_of_breast|Familial_cancer_of_breast|Breast_and_colorectal_cancer,_susceptibility_to|not_provided|not_provided|not_provided|Colorectal_cancer|Neoplasm_of_the_breast|Familial_cancer_of_breast/Li-Fraumeni_syndrome_2/Osteosarcoma/Malignant_tumor_of_prostate|Hereditary_breast_and_ovarian_cancer_syndrome|CHEK2-Related_Cancer_Susceptibility	||In_silico_models_in_agreement_(deleterious)_and/or_completely_conserved_position_in_appropriate_species:Significant_disease_association_in_appropriately_sized_case-control_study(ies):Good_segregation_with_disease_(lod_1.5-3_	TCGA_UCEC_044
NM_058216.2:c.965+5G>A	RAD51C	splice_region_variant,intron_variant	-	-	-	-	409841	402642	_complementation_group_O	-	MedGen:C0027672,SNOMED_CT:699346009|MedGen:C3150653,OMIM:613390	-	NC_000017.10:g.56801466G>A	_conflicting_interpretations	Conflicting_interpretations_of_pathogenicity	Uncertain_significance(2)	-	single_nucleotide_variant	SO:0001483	-	-	RAD51C:5889	SO:0001627|intron_variant	1	774586107	-	Invitae|Ambry_Genetics|Color	Uncertain_significance|Likely_pathogenic|Uncertain_significance	2016-06-04|2018-05-30|2018-08-24	2017-03-14|2020-02-26|2018-11-06	criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter	germline|germline|germline	SCV000550196|SCV000663788|SCV000686408	_complementation_group_O|Hereditary_cancer-predisposing_syndrome|Hereditary_cancer-predisposing_syndrome	This_variant_affects_a_highly_conserved_nucleotide_within_the_consensus_splice_site_of_intron_7._The_majority_of_introns_(75%)_have_a_G_nucleotide_at_this_position_(PMID:_9536098)._This_variant_is_present_in_population_databases_(rs774586107,_ExAC_0.002%)._This_variant_has_been_reported_in_in_an_individual_affected_with_ovarian_cancer_(PMID:_22725699)._RT-PCR_analysis_of_mRNA_isolated_from_patient_blood_cells_showed_that_this_variant_leads_to_skipping_of_exon_7_(PMID:_22725699)._In_summary,_this_variant_has_been_reported_in_both_the_population_and_in_an_affected_individual,_and_it_is_likely_to_cause_a_splicing_defect._However,_without_additional_functional_and/or_genetic_data,_this_variant_has_been_classified_as_a_Variant_of_Uncertain_Significance.|Functionally-validated_splicing_mutation:Other_strong_data_supporting_pathogenic_classification:Rarity_in_general_population_databases_(dbsnp,_esp,_1000_genomes)|	TCGA_UCEC_061
NM_002485.4:c.643C>T	NBN	missense_variant	3	1	rs34767364	Hereditary cancer-predisposing syndrome	6948	21987	_normal_intelligence_and_immunodeficiency|not_specified|not_provided	-	MedGen:C0027672,SNOMED_CT:699346009|MedGen:C0398791,OMIM:251260,Orphanet:ORPHA647,SNOMED_CT:234638009|MedGen:CN169374|MedGen:CN517202	-	NC_000008.10:g.90983460G>A	_conflicting_interpretations	Conflicting_interpretations_of_pathogenicity	Benign(2),Likely_benign(4),Uncertain_significance(7)	-	single_nucleotide_variant	SO:0001483	UniProtKB_(protein):O60934#VAR_025799|ARUP_Laboratories,_Molecular_Genetics_and_Genomics,_ARUP_Laboratories:102952|OMIM_Allelic_Variant:602667.0009	-	NBN:4683	SO:0001583|missense_variant	1	34767364	-	OMIM|GeneReviews|Counsyl|Mendelics|Ambry_Genetics|Color|True_Health_Diagnostics|GeneKor_MSA|ITMI|Genetic_Services_Laboratory,_University_of_Chicago|ARUP_Laboratories,_Molecular_Genetics_and_Genomics,_ARUP_Laboratories|Invitae|EGL_Genetic_Diagnostics,Eurofins_Clinical_Diagnostics|CeGaT_Praxis_fuer_Humangenetik_Tuebingen|Quest_Diagnostics_Nichols_Institute_San_Juan_Capistrano|Integrated_Genetics/Laboratory_Corporation_of_America|PreventionGenetics,PreventionGenetics	Pathogenic|Pathogenic|Uncertain_significance|Likely_benign|Likely_benign|Benign|Likely_benign|Uncertain_significance|not_provided|Uncertain_significance|Likely_benign|Benign|Uncertain_significance|Uncertain_significance|Likely_benign|Uncertain_significance|Uncertain_significance	2006-03-01|2017-02-02|2017-03-24|2018-07-02|2019-04-28|2014-12-12|2017-09-05|2018-08-01|2013-09-19|2016-05-05|2018-07-24|2019-03-04|2018-06-07|2019-02-01|2019-01-15|2017-02-02|2016-08-23	2016-10-11|2017-02-02|2018-07-10|2018-08-20|2020-02-26|2017-10-26|2018-03-08|2018-08-08|2014-05-29|2017-07-05|2019-08-05|2019-03-14|2018-09-19|2019-07-12|2020-03-06|2018-01-25|2018-01-29	no_assertion_criteria_provided|no_assertion_criteria_provided|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|no_assertion_criteria_provided|criteria_provided,_single_submitter|no_assertion_provided|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter	germline|germline|unknown|unknown|germline|germline|germline|germline|germline|germline|germline|germline|germline|germline|germline|germline|germline	SCV000027562|SCV000494626|SCV000800508|SCV000838311|SCV000184001|SCV000685805|SCV000788081|SCV000822089|SCV000085819|SCV000595910|SCV000604434|SCV000166524|SCV000231654|SCV000575564|SCV000601698|SCV000697976|SCV000806447	Microcephaly,_normal_intelligence_and_immunodeficiency|Microcephaly,_normal_intelligence_and_immunodeficiency|Microcephaly,_normal_intelligence_and_immunodeficiency|Microcephaly,_normal_intelligence_and_immunodeficiency|Hereditary_cancer-predisposing_syndrome|Hereditary_cancer-predisposing_syndrome|Hereditary_cancer-predisposing_syndrome|Hereditary_cancer-predisposing_syndrome|not_specified|not_specified|not_specified|not_provided|not_provided|not_provided|not_provided|not_provided|not_provided	||||Intact_protein_function_observed_in_appropriate_functional_assay(s):Subpopulation_frequency_in_support_of_benign_classification:Seen_in_trans_with_a_mutation_or_in_homozygous_state_in_individual_without_severe_disease_for_that_gene:General_population_or_subpopulation_frequency_is_too_high_to_be_a_pathogenic_mutation_based_on_disease/syndrome_prevalence_and_penetrance|||||||||||Variant_summary:_The_NBN_c.643C>T_(p.Arg215Trp)_variant_involves_the_alteration_of_a_non-conserved_nucleotide._4/4_in_silico_tools_predict_a_damaging_outcome_for_this_variant_(SNPs&GO_not_captured_due_to_low_reliability_index)._This_variant_was_found_in_392/138390_control_chromosomes_(including_3_homozygotes)_at_a_frequency_of_0.0028326,_which_greater_(1.13_time)_than_the_estimated_maximal_expected_allele_frequency_of_a_pathogenic_NBN_variant_(0.0025)_based_on_the_disease_prevalence_of_NBS_(1_in_100000),_suggesting_this_variant_is_likely_a_benign_polymorphism._However,_the_frequency_in_general_population_is_in_sub-polymorphic_range_and_these_data_alone_cannot_rule_out_the_possibility_that_it_can_still_have_a_role_as_a_risk_variant_in_disease._Pathogenic_variants_in_this_gene_are_monogenically_linked_with_NBS_(Nijmegen_Breakage_Syndrome)_-_an_autosomal_recessive_disorder_as_well_as_associated_with_increased_risks_for_various_cancers._The_variant_has_been_reported_in_patients_with_various_cancers_such_as_breast_cancer,_leukemia,_prostate_cancer,_ovarian_cancer,_melanoma,_colorectal_cancer,_lung_cancer_etc._However,_it_has_not_been_reported_to_have_a_considerably_significant_association_with_other_forms_of_cancer_(Taylor_2003,_Hebbring_2006,_Bogdanovaas_2008,_Dzikiewicz-Krawczyk_2012,_and_Ramus_2014)._This_is_consistent_with_studies_reporting_95%_CI_around_the_OR_to_include_1.0,_thereby_providing_little_to_no_confidence_on_the_strength_of_the_assertions._Specifically,_this_variant_was_not_significantly_associated_with_increased_risk_for_breast_cancer_(Bogdanova_IJC_2008)_(adjusted_OR_	TCGA_UCEC_084;TCGA_UCEC_380
NM_000038.5:c.3949G>C	APC	missense_variant	2	0	rs1801166	not provided	829	15868	Hereditary_cancer-predisposing_syndrome|Familial_adenomatous_polyposis_1|not_specified|APC-Associated_Polyposis_Disorders|not_provided	-	MedGen:C0027672,SNOMED_CT:699346009|MedGen:C2713442,OMIM:175100|MedGen:CN169374|MedGen:CN239210|MedGen:CN517202	-	NC_000005.9:g.112175240G>C	_conflicting_interpretations	Conflicting_interpretations_of_pathogenicity	Benign(8),Likely_benign(5),Uncertain_significance(1)	-	single_nucleotide_variant	SO:0001483	Illumina_Clinical_Services_Laboratory,Illumina:65344|Quest_Diagnostics_Nichols_Institute_San_Juan_Capistrano:2686298|ARUP_Laboratories,_Molecular_Genetics_and_Genomics,_ARUP_Laboratories:3381|UniProtKB_(protein):P25054#VAR_009617|Mayo_Clinic_Genetic_Testing_Laboratories,Mayo_Clinic:86|OMIM_Allelic_Variant:611731.0036	-	APC:324	SO:0001583|missense_variant	1	1801166	-	OMIM|GeneReviews|Pathway_Genomics|Counsyl|Mendelics|Biochemical_Molecular_Genetic_Laboratory,King_Abdulaziz_Medical_City|Biesecker_Lab/Clinical_Genomics_Section,National_Institutes_of_Health|Invitae|CeGaT_Praxis_fuer_Humangenetik_Tuebingen|Quest_Diagnostics_Nichols_Institute_San_Juan_Capistrano|Laboratory_for_Molecular_Medicine,_Partners_HealthCare_Personalized_Medicine|ITMI|GeneDx|EGL_Genetic_Diagnostics,Eurofins_Clinical_Diagnostics|Mayo_Clinic_Genetic_Testing_Laboratories,Mayo_Clinic|PreventionGenetics,PreventionGenetics|Department_of_Pathology_and_Laboratory_Medicine,Sinai_Health_System|ARUP_Laboratories,_Molecular_Genetics_and_Genomics,_ARUP_Laboratories|Illumina_Clinical_Services_Laboratory,Illumina|Color|True_Health_Diagnostics|Ambry_Genetics	Pathogenic|pathologic|Likely_benign|Likely_benign|Uncertain_significance|Benign|no_known_pathogenicity|Benign|Likely_benign|Benign|Likely_benign|not_provided|Benign|Benign|Uncertain_significance|Benign|Benign|Benign|Likely_benign|Benign|Likely_benign|Likely_benign	2000-09-22|2011-10-27|2014-07-24|2017-05-18|2018-07-02|2020-02-05|2012-07-13|2019-03-05|2017-05-01|2018-03-23|2017-05-08|2013-09-19|2013-10-10|2014-12-03|0000-00-00|0000-00-00|2016-02-05|2018-07-06|2016-06-14|2016-03-21|2017-08-11|2019-12-26	2016-10-20|2013-01-08|2014-08-08|2018-06-20|2018-08-20|2020-02-12|0000-00-00|2019-03-14|2019-07-12|2018-08-31|2019-03-21|2014-05-29|2018-03-26|2018-09-19|2017-10-31|2016-04-28|2017-04-19|2019-08-05|2016-10-18|2017-10-26|2017-11-15|2020-02-26	no_assertion_criteria_provided|no_assertion_criteria_provided|no_assertion_criteria_provided|criteria_provided,_single_submitter|criteria_provided,_single_submitter|no_assertion_criteria_provided|no_assertion_criteria_provided|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|no_assertion_provided|criteria_provided,_single_submitter|criteria_provided,_single_submitter|no_assertion_criteria_provided|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|no_assertion_criteria_provided|criteria_provided,_single_submitter	germline|not_provided|germline|unknown|unknown|germline|germline|germline|germline|germline|germline|germline|germline|germline|unknown|germline|germline|germline|germline|germline|germline|germline	SCV000021022|SCV000040394|SCV000189869|SCV000785169|SCV000838111|SCV001190845|SCV000043126|SCV000153870|SCV000609169|SCV000888740|SCV000058713|SCV000084172|SCV000167008|SCV000226386|SCV000256984|SCV000301593|SCV000591162|SCV000602523|SCV000452009|SCV000681643|SCV000693481|SCV001183123	Familial_adenomatous_polyposis_1|Familial_adenomatous_polyposis_1|Familial_adenomatous_polyposis_1|Familial_adenomatous_polyposis_1|Familial_adenomatous_polyposis_1|Familial_adenomatous_polyposis_1|not_provided|not_provided|not_provided|not_provided|not_specified|not_specified|not_specified|not_specified|not_specified|not_specified|not_specified|not_specified|APC-Associated_Polyposis_Disorders|Hereditary_cancer-predisposing_syndrome|Hereditary_cancer-predisposing_syndrome|Hereditary_cancer-predisposing_syndrome	|Converted_during_submission_to_Pathogenic.|||||Converted_during_submission_to_Benign.||||Disclaimer:_This_variant_has_not_undergone_full_assessment._The_following_are_pr_eliminary_notes:_This_variant_is_classified_in_HGMD_as_DP_and_is_present_in_12_p_apers,_with_comments_suggesting_non-pathogenicity._It_is_present_at_0.62%_in_gno_mAD_(785/126536_European_chrs,_including_7_homozygotes)._It_is_classified_in_Cli_nVar_with_1_star_as_Benign/Likely_benign_by_Invitae,_GeneDx,_Emory,_Prevention_G_enetics,_Biesecker_lab,_and_Pathway_Genomics._2_mammals_have_a_Gln_at_this_posit_ion.||This_variant_is_considered_likely_benign_or_benign_based_on_one_or_more_of_the_following_criteria:_it_is_a_conservative_change,_it_occurs_at_a_poorly_conserved_position_in_the_protein,_it_is_predicted_to_be_benign_by_multiple_in_silico_algorithms,_and/or_has_population_frequency_not_consistent_with_disease.|||||||||	TCGA_UCEC_101;TCGA_UCEC_124;TCGA_UCEC_155;TCGA_UCEC_247;TCGA_UCEC_247;TCGA_UCEC_272;TCGA_UCEC_360;TCGA_UCEC_360;TCGA_UCEC_360;TCGA_UCEC_454;TCGA_UCEC_470
NM_007194.3:c.1427C>T	CHEK2	missense_variant	4&4	1&1	rs142763740	Hereditary cancer-predisposing syndrome&not provided	128060	133517	_susceptibility_to|not_specified|CHEK2-Related_Cancer_Susceptibility|not_provided	-	Human_Phenotype_Ontology:HP:0100013,MeSH:D001943,MedGen:C1458155,Orphanet:ORPHA180250,SNOMED_CT:126926005|MedGen:C0006142,OMIM:114480,Orphanet:ORPHA227535,SNOMED_CT:254843006|MedGen:C0027672,SNOMED_CT:699346009|MedGen:C1527249|MedGen:C1858433|MedGen:CN169374|MedGen:CN239278|MedGen:CN517202	-	NC_000022.10:g.29090054G>A	_conflicting_interpretations	Conflicting_interpretations_of_pathogenicity	Uncertain_significance(8)	-	single_nucleotide_variant	SO:0001483	Illumina:655839	-	CHEK2:11200	SO:0001583|missense_variant	17	142763740	-	Ambry_Genetics|Institute_for_Biomarker_Research,Medical_Diagnostic_Laboratories,_L.L.C.|GeneID_Lab_-_Advanced_Molecular_Diagnostics|Color|GeneKor_MSA|Invitae|HudsonAlpha_Institute_for_Biotechnology,_HudsonAlpha_Institute_for_Biotechnology|Counsyl|Mendelics|University_of_Washington_Department_of_Laboratory_Medicine,_University_of_Washington|GeneDx|Quest_Diagnostics_Nichols_Institute_San_Juan_Capistrano|Integrated_Genetics/Laboratory_Corporation_of_America|PreventionGenetics,PreventionGenetics|Illumina_Clinical_Services_Laboratory,Illumina|Illumina_Clinical_Services_Laboratory,Illumina|Genetic_Services_Laboratory,_University_of_Chicago|Illumina_Clinical_Services_Laboratory,Illumina	Likely_pathogenic|Likely_pathogenic|Likely_pathogenic|Uncertain_significance|Likely_pathogenic|Uncertain_significance|Uncertain_significance|Uncertain_significance|Likely_pathogenic|Uncertain_significance|Likely_pathogenic|Likely_pathogenic|Uncertain_significance|Likely_pathogenic|Uncertain_significance|Likely_pathogenic|Uncertain_significance|Likely_pathogenic	2019-08-16|2017-02-14|2017-09-07|2018-10-03|2018-08-01|2018-12-30|2018-04-16|2017-10-06|2018-07-02|2015-11-20|2019-01-07|2018-12-10|2016-10-14|2016-09-30|2016-06-14|2016-06-14|2016-11-21|2017-04-27	2020-02-26|2017-02-16|2017-09-11|2018-11-06|2018-08-08|2019-03-28|2018-05-24|2018-06-20|2018-08-20|2016-03-03|2019-01-29|2020-03-06|2018-01-25|2018-01-29|2016-10-18|2016-10-18|2017-07-05|2019-02-01	criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter	germline|germline|germline|germline|germline|germline|unknown|unknown|unknown|germline|germline|germline|germline|germline|germline|germline|germline|germline	SCV000186804|SCV000576430|SCV000680448|SCV000689655|SCV000821724|SCV000254925|SCV000778585|SCV000785095|SCV000839455|SCV000266166|SCV000149910|SCV000601155|SCV000698777|SCV000806869|SCV000437713|SCV000437714|SCV000594113|SCV000914986	_susceptibility_to|not_provided|not_provided|not_provided|not_provided|Colorectal_cancer|Neoplasm_of_the_breast|not_specified|CHEK2-Related_Cancer_Susceptibility	Detected_in_individual_satisfying_established_diagnostic_critera_for_classic_disease_without_a_clear_mutation:Deficient_protein_function_in_appropriate_functional_assay(s)|||||This_sequence_change_replaces_threonine_with_methionine_at_codon_476_of_the_CHEK2_protein_(p.Thr476Met)._The_threonine_residue_is_highly_conserved_and_there_is_a_moderate_physicochemical_difference_between_threonine_and_methionine._This_variant_is_present_in_population_databases_(rs142763740,_ExAC_0.07%)._This_variant_has_been_reported_in_individuals_affected_with_breast_cancer_(PMID:_21244692),_endometrial_cancer_(PMID:_27443514),_colorectal_cancer_(PMID:Â¬â€ 28944238),_prostate_cancer_(PMID:Â¬â€ 29368341,Â¬â€ 29520813),_and_in_a_male_with_breast_and_colon_cancer_(PMID:_28008555)._ClinVar_contains_an_entry_for_this_variant_(Variation_ID:_128060)._Experimental_studies_have_shown_that_this_missense_change_disrupts_CHEK2_kinase_activity_in_vitro_and_impairs_DNA_damage_response_in_a_yeast_assay_(PMID:_22114986,_22419737)._In_summary,_the_available_evidence_is_currently_insufficient_to_determine_the_role_of_this_variant_in_disease._Therefore,_it_has_been_classified_as_a_Variant_of_Uncertain_Significance.|||||This_variant_is_denoted_CHEK2_c.1427C>T_at_the_cDNA_level,_p.Thr476Met_(T476M)_at_the_protein_level,_and_results_in_the_change_of_a_Threonine_to_a_Methionine_(ACG>ATG)._This_variant_has_been_reported_in_individuals_with_a_personal_and/or_family_history_of_breast,_pancreatic,_or_prostate_cancer_(Desrichard_2011,_Le_Calvez-Kelm_2011,_Hu_2015,_Leedom_2016,_Pritzlaff_2016,_Shirts_2016,_Frey_2017,_Isaacsson_Velho_2018,_Schubert_2018,_Wu_2018)._This_variant_was_shown_in_an_in_vitro_study_to_abolish_kinase_activity,_and_was_shown_in_an_in_vivo_study_to_impair_CHEK2-mediated_response_to_DNA_damage_(Desrichard_2011,_Roeb_2012)._A_different_nucleotide_change_(CHEK2_c.1427C>A)_resulting_in_the_same_amino_acid_substitution_was_identified_in_a_patient_with_a_clinical_diagnosis_of_Li-Fraumeni_syndrome_(Sadri_2014)._Although_this_variant_was_observed_in_large_population_cohorts,_population_data_in_this_region_of_CHEK2_are_not_considered_reliable_due_to_high_pseudogene_homology_(Lek_2016)._CHEK2_Thr476Met_is_located_in_the_protein_kinase_domain_(Cai_2009,_Roeb_2012)._In_silico_analysis,_which_includes_protein_predictors_and_evolutionary_conservation,_supports_a_deleterious_effect._Based_on_the_currently_available_evidence,_we_consider_CHEK2_Thr476Met_to_be_a_likely_pathogenic_variant.|The_best_available_variant_frequency_is_uninformative._Statistically_enriched_in_patients_compared_to_ethnically_matched_controls._Found_in_at_least_one_symptomatic_patient._Predicted_to_have_a_damaging_effect_on_the_protein._Occurs_in_a_single_case_with_an_otherwise_positive_result._Assessment_of_experimental_evidence_suggests_this_variant_results_in_abnormal_protein_function.||||Across_three_studies,_the_c.1427C>T_(p.Thr476Met),_was_reported_in_five_of_1,955_breast_cancer_patients_(Le_Calvez-Kelm_et_al._2011:_Desrichard_et_al._2011:_Angelova_et_al._2012)._The_variant_was_absent_from_a_total_of_1,622_controls,_but_is_reported_at_a_frequency_of_0.00068_in_the_European_(Non-Finnish)_population_of_the_Exome_Aggregation_Consortium._Desrichard_et_al._(2011)_developed_an_in_vitro_kinase_activity_assay_to_assess_the_activity_of_missense_variants_in_CHEK2._In_this_assay_the_p.Thr476Met_variant_demonstrated_no_kinase_activity_and_was_similar_to_a_known_non-functional_kinase_variant_of_CHEK2._In_addition,_Roeb_et_al._(2012)_developed_a_yeast-based_in-vivo_functional_assay_to_assess_the_effect_of_CHEK2_variants_on_the_repair_of_DNA_damage._Cells_with_wild-type_CHEK2_repaired_the_DNA_damage_while_cells_with_a_known_non-functional_variant_of_CHEK2_did_not._The_p.Thr476Met_variant_was_shown_to_have_loss_of_function_by_this_DNA_damage_response_assay._Based_on_the_evidence,_the_p.Thr476Met_variant_is_classified_as_likely_pathogenic_for_breast_cancer.||The_CHEK2_c.1427C>T_(p.Thr476Met)_missense_variant,_also_referred_to_as_c.1556C>T_(p.Thr519Met),_was_reported_in_five_of_1,955_breast_cancer_patients_(Le_Calvez-Kelm_et_al._2011:_Desrichard_et_al._2011:_Angelova_et_al._2012)._The_variant_was_absent_from_a_total_of_1,622_controls,_but_is_reported_at_a_frequency_of_0.00068_in_the_European_(non-Finnish)_population_of_the_Exome_Aggregation_Consortium._Desrichard_et_al._(2011)_developed_an_in_vitro_kinase_activity_assay_to_assess_the_activity_of_missense_variants_in_CHEK2._In_this_assay_the_p.Thr476Met_variant_demonstrated_no_kinase_activity_and_was_similar_to_a_known_non-functional_kinase_variant_of_CHEK2._In_addition,_Roeb_et_al._(2012)_developed_a_yeast-based_in-vivo_functional_assay_to_assess_the_effect_of_CHEK2_variants_on_the_repair_of_DNA_damage._Cells_with_wild_type_CHEK2_repaired_the_DNA_damage_while_cells_with_a_known_non-functional_variant_of_CHEK2_did_not._The_p.Thr476Met_variant_was_shown_to_have_loss_of_function_by_this_DNA_damage_response_assay._Based_on_the_evidence,_the_p.Thr476Met_variant_is_classified_as_pathogenic_for_CHEK2-related_cancer_susceptibility._This_variant_was_observed_by_ICSL_as_part_of_a_predisposition_screen_in_an_ostensibly_healthy_population.	TCGA_UCEC_160
NM_007194.3:c.470T>C	CHEK2	missense_variant	5&5&4&4	0&2&1&1	rs17879961	Li-Fraumeni syndrome 2&Hereditary cancer-predisposing syndrome&Breast and colorectal cancer, susceptibility to&not provided	5591	20630	Cancer_of_multiple_types,_susceptibility_to|Prostate_cancer,_susceptibility_to|Gastrointestinal_carcinoma|Adrenocortical_carcinoma|Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|Li-Fraumeni_syndrome_2|Breast_and_colorectal_cancer,_susceptibility_to|Colorectal_cancer,_susceptibility_to|Breast_cancer,_susceptibility_to|COLON_CANCER,_SUSCEPTIBILITY_TO|not_specified|not_provided	-	.|.|Human_Phenotype_Ontology:HP:0002672,MedGen:C0151544|Human_Phenotype_Ontology:HP:0006744,MeSH:D018268,MedGen:C0206686,Orphanet:ORPHA1501|MedGen:C0006142,OMIM:114480,Orphanet:ORPHA227535,SNOMED_CT:254843006|MedGen:C0027672,SNOMED_CT:699346009|MedGen:C1836482,OMIM:609265|MedGen:C1858433|MedGen:C1858438|MedGen:C3469522|MedGen:C4016820|MedGen:CN169374|MedGen:CN517202	-	NC_000022.10:g.29121087A>G	_conflicting_interpretations	Conflicting_interpretations_of_pathogenicity	Likely_pathogenic(7),Pathogenic(7),Uncertain_significance(3)	-	single_nucleotide_variant	SO:0001483	ARUP_Laboratories,_Molecular_Genetics_and_Genomics,_ARUP_Laboratories:181664|OMIM_Allelic_Variant:604373.0002|UniProtKB_(protein):O96017#VAR_008555	-	CHEK2:11200	SO:0001583|missense_variant,SO:0001623|5_prime_UTR_variant,SO:0001627|intron_variant	1	17879961	-	OMIM|OMIM|OMIM|OMIM|Ambry_Genetics|Color|True_Health_Diagnostics|GeneKor_MSA|ITMI|Integrated_Genetics/Laboratory_Corporation_of_America|ARUP_Laboratories,_Molecular_Genetics_and_Genomics,_ARUP_Laboratories|Pathway_Genomics|Invitae|Counsyl|Mendelics|Human_Genome_Sequencing_Center_Clinical_Lab,Baylor_College_of_Medicine|Center_of_Medical_Genetics_and_Primary_Health_Care|University_of_Washington_Department_of_Laboratory_Medicine,_University_of_Washington|Division_of_Genomic_Diagnostics,The_Children's_Hospital_of_Philadelphia|GeneDx|CeGaT_Praxis_fuer_Humangenetik_Tuebingen|Quest_Diagnostics_Nichols_Institute_San_Juan_Capistrano|Mayo_Clinic_Genetic_Testing_Laboratories,Mayo_Clinic|PreventionGenetics,PreventionGenetics|Genetic_Services_Laboratory,_University_of_Chicago|Centre_for_Mendelian_Genomics,University_Medical_Centre_Ljubljana|GenomeConnect,_ClinGen	Pathogenic|risk_factor|risk_factor|risk_factor|Pathogenic|Pathogenic|Pathogenic|Likely_pathogenic|not_provided|Uncertain_significance|Pathogenic|Likely_pathogenic|Pathogenic|Likely_pathogenic|Likely_pathogenic|Pathogenic|Pathogenic|Likely_pathogenic|Likely_pathogenic|Likely_pathogenic|Uncertain_significance|Pathogenic|Pathogenic|Likely_pathogenic|Pathogenic|Uncertain_significance|not_provided	2006-11-01|2006-11-01|2006-11-01|2006-11-01|2018-06-20|2014-12-26|2017-11-16|2018-08-01|2013-09-19|2019-04-15|2019-01-02|2014-07-24|2019-01-09|2016-03-15|2018-07-02|2017-06-02|0000-00-00|2015-11-20|2018-05-03|2019-09-30|2019-04-01|2017-02-17|0000-00-00|2016-09-14|2017-06-13|2017-01-01|0000-00-00	2011-11-22|2011-11-22|2011-11-22|2011-11-22|2020-02-26|2016-07-05|2018-03-08|2018-08-08|2014-05-29|2019-09-24|2019-08-05|2014-08-08|2019-03-28|2017-06-22|2018-08-20|2018-06-14|2019-08-31|2016-03-03|2018-05-04|2020-01-06|2019-07-12|2017-08-01|2017-10-31|2018-01-29|2017-07-05|2017-12-08|2019-01-30	no_assertion_criteria_provided|no_assertion_criteria_provided|no_assertion_criteria_provided|no_assertion_criteria_provided|criteria_provided,_single_submitter|criteria_provided,_single_submitter|no_assertion_criteria_provided|criteria_provided,_single_submitter|no_assertion_provided|criteria_provided,_single_submitter|criteria_provided,_single_submitter|no_assertion_criteria_provided|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|no_assertion_criteria_provided|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|no_assertion_criteria_provided|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|no_assertion_provided	germline|germline|germline|germline|germline|germline|germline|germline|germline|germline|germline|germline|germline|unknown|unknown|germline|germline|germline|germline|germline|germline|germline|unknown|germline|germline|unknown|unknown	SCV000026118|SCV000026119|SCV000026120|SCV000026121|SCV000183804|SCV000292120|SCV000788004|SCV000821722|SCV000084709|SCV000698803|SCV001159433|SCV000189923|SCV000253984|SCV000677722|SCV000839491|SCV000839939|SCV000987254|SCV000266064|SCV000296968|SCV000149927|SCV000575329|SCV000601169|SCV000691835|SCV000806880|SCV000594119|SCV000747421|SCV000986797	Li-Fraumeni_syndrome_2|Colorectal_cancer,_susceptibility_to|Cancer_of_multiple_types,_susceptibility_to|Prostate_cancer,_susceptibility_to|Hereditary_cancer-predisposing_syndrome|Hereditary_cancer-predisposing_syndrome|Hereditary_cancer-predisposing_syndrome|Hereditary_cancer-predisposing_syndrome|not_specified|not_specified|not_specified|Familial_cancer_of_breast|Familial_cancer_of_breast|Familial_cancer_of_breast|Familial_cancer_of_breast|Familial_cancer_of_breast|Familial_cancer_of_breast|Breast_and_colorectal_cancer,_susceptibility_to|Breast_and_colorectal_cancer,_susceptibility_to|not_provided|not_provided|not_provided|not_provided|not_provided|Breast_cancer,_susceptibility_to|Gastrointestinal_carcinoma/Adrenocortical_carcinoma|Breast_cancer,_susceptibility_to/COLON_CANCER,_SUSCEPTIBILITY_TO	||||Significant_disease_association_in_appropriately_sized_case-control_study(ies):Deficient_protein_function_in_appropriate_functional_assay(s):Other_strong_data_supporting_pathogenic_classification|||||Variant_summary:_CHEK2_c.470T>C_(p.Ile157Thr)_results_in_a_non-conservative_amino_acid_change_located_in_the_Forkhead-associated_(FHA)_domain_(IPR000253)_of_the_encoded_protein_sequence._Four_of_five_in-silico_tools_predict_a_damaging_effect_of_the_variant_on_protein_function._The_variant_allele_was_found_at_a_frequency_of_0.0042_in_253524_control_chromosomes_in_the_gnomAD_database,_including_11_homozygotes._The_observed_variant_frequency_is_approximately_13.5_fold_of_the_estimated_maximal_expected_allele_frequency_for_a_pathogenic_variant_in_CHEK2_causing_Hereditary_Breast_and_Ovarian_Cancer_phenotype_(0.00031)._In_addition,_this_variant_has_been_reported_in_47/7325_European_American_women_(including_1_homozygote)_who_are_older_than_age_70_and_cancer_free_(in_the_FLOSSIES_database)._These_data_suggest_that_the_variant_is_benign_polymorphism._However,_c.470T>C_has_been_reported_in_the_literature_in_several_individuals_affected_with_Hereditary_Breast_and_Ovarian_Cancer._In_families_with_this_variant,_transmissions_of_the_variant_allele_and_transmissions_of_the_reference_allele_to_affected_individuals_was_reported_in_addition_to_unaffected_individuals_who_harbored_the_variant_(Allinen_2001,_Dong_2003,_Roeb_2012,_Bak_2014,_Cragun_2014,_Stradella_2018)._These_data_indicate_that_the_variant_is_likely_to_be_associated_with_disease_but_also_suggests_incomplete_segregation_and_incomplete_penetrance_associated_with_this_variant._Co-occurrences_with_other_pathogenic_variants_have_been_reported_in_CHEK2_as_well_as_in_other_genes_associated_with_cancer_(e.g._BRCA2_c.6468_6469delTC_[p.Gln2157fsX18]:_NBN_c.657_661delACAAA_[p.Lys219fsX16]:_BRCA1_c.3700_3704delGTAAA_[p.Val1234fsX8]:_CHEK2_c.444+1G>A:_CHEK2_1100delC_[p.Thr367fsX15]:_CHEK2_c.433C>T_[p.Arg145Trp]),_providing_supporting_evidence_for_a_benign_role,_though_in_some_of_these_cases_the_observed_phenotype_(earlier_onset),_could_also_suggest_an_additive_effect_(Stradella_2018)._Multiple_association_studies_have_produced_conflicting_results,_but_with_an_overall_consensus_for_the_variant_being_associated_with_a_moderate_increased_risk_for_breast_cancer_based_on_a_large_meta-analysis_by_Liu_2012_that_included_a_total_of_fifteen_case-control_studies_(19,621_cases_and_27,001_controls),_showing_a_significant_association_for_unselected_breast_cancer_(OR_	TCGA_UCEC_285;TCGA_UCEC_471;TCGA_UCEC_471
NM_000051.3:c.7775C>G	ATM	missense_variant	-	-	-	-	186713	183406	Ataxia-telangiectasia_syndrome|Hereditary_cancer-predisposing_syndrome|not_provided	-	MedGen:C0004135,OMIM:208900,Orphanet:ORPHA100,SNOMED_CT:68504005|MedGen:C0027672,SNOMED_CT:699346009|MedGen:CN517202	-	NC_000011.9:g.108202751C>G	_conflicting_interpretations	Conflicting_interpretations_of_pathogenicity	Uncertain_significance(4)	-	single_nucleotide_variant	SO:0001483	-	-	ATM:472|C11orf65:160140	SO:0001627|intron_variant	1	755009196	-	_University_of_Cambridge|Invitae|GeneDx	Uncertain_significance|Uncertain_significance|Likely_pathogenic|Uncertain_significance|Uncertain_significance	2019-02-11|2018-08-05|2018-01-26|2018-12-24|2018-06-14	2020-02-26|2018-11-06|2018-04-23|2019-03-28|2019-01-29	criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter	germline|germline|germline|germline|germline	SCV000217143|SCV000687787|SCV000992205|SCV000283062|SCV000293440	Hereditary_cancer-predisposing_syndrome|Hereditary_cancer-predisposing_syndrome|Hereditary_cancer-predisposing_syndrome|Ataxia-telangiectasia_syndrome|not_provided	Insufficient_or_conflicting_evidence:Deficient_protein_function_in_appropriate_functional_assay(s):Rarity_in_general_population_databases_(dbsnp,_esp,_1000_genomes):In_silico_models_in_agreement_(deleterious)_and/or_completely_conserved_position_in_appropriate_species||Application_of_AMCG_guidelines_2015._Used_other_ClinVar_submission_evidence_where_relevant._Loss_of_heterozygosity_in_tumours_or_immunohistochemistry_abnormalities_considered_functional_evidence_of_pathogenicity.|This_sequence_change_replaces_serine_with_cysteine_at_codon_2592_of_the_ATM_protein_(p.Ser2592Cys)._The_serine_residue_is_highly_conserved_and_there_is_a_moderate_physicochemical_difference_between_serine_and_cysteine._This_variant_is_present_in_population_databases_(rs755009196,_ExAC_<0.01%)._This_variant_has_been_observed_in_individuals_affected_with_breast_cancer,_prostate_cancer,_orÂ¬â€ Non-Hodgkin's_lymphomaÂ¬â€ (PMID:_11606401,_11805335,_19781682,Â¬â€ 29909963,Â¬â€ 28825054,_17640065)._Segregation_studies_have_not_been_reported_for_this_variant._ClinVar_contains_an_entry_for_this_variant_(Variation_ID:_186713)._Experimental_in_vitro_studies_have_shown_that_this_missense_change_abolishes_ATM_kinase_activity_and_increases_radiosensitivity_(PMID:_11805335)._In_summary,_the_available_evidence_is_currently_insufficient_to_determine_the_role_of_this_variant_in_disease._Therefore,_it_has_been_classified_as_a_Variant_of_Uncertain_Significance.|This_variant_is_denoted_ATM_c.7775C>G_at_the_cDNA_level,_p.Ser2592Cys_(S2592C)_at_the_protein_level,_and_results_in_the_change_of_a_Serine_to_a_Cysteine_(TCT>TGT)._This_variant_has_been_reported_in_individuals_with_breast_and_prostate_cancer,_as_well_as_in_a_healthy_control_(Dork_2001,_Tavtigian_2009,_Caminsky_2016,_Abida_2017,_Decker_2017)._Scott_et_al._(2002)_reported_that_ATM_Ser2592Cys_is_associated_with_absent_kinase_activity_and_increased_radiosensitivity_in_vitro,_and_the_authors_suggest_that_this_variant_produces_a_dominant_interfering_effect._ATM_Ser2592Cys_was_not_observed_at_a_significant_allele_frequency_in_large_population_cohorts_(Lek_2016)._This_variant_is_not_located_in_a_known_functional_domain._In_silico_analysis,_which_includes_protein_predictors_and_evolutionary_conservation,_supports_a_deleterious_effect._Based_on_currently_available_evidence,_it_is_unclear_whether_ATM_Ser2592Cys_is_a_pathogenic_or_benign_variant._We_consider_it_to_be_a_variant_of_uncertain_significance.	TCGA_UCEC_290
NM_000051.3:c.5821G>C	ATM	missense_variant	-	-	-	-	127412	132869	Ataxia-telangiectasia_syndrome|Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided	-	MedGen:C0004135,OMIM:208900,Orphanet:ORPHA100,SNOMED_CT:68504005|MedGen:C0006142,OMIM:114480,Orphanet:ORPHA227535,SNOMED_CT:254843006|MedGen:C0027672,SNOMED_CT:699346009|MedGen:CN169374|MedGen:CN517202	-	NC_000011.9:g.108180945G>C	_conflicting_interpretations	Conflicting_interpretations_of_pathogenicity	Uncertain_significance(11)	-	single_nucleotide_variant	SO:0001483	-	-	ATM:472|C11orf65:160140	SO:0001627|intron_variant	1	147187700	-	Ambry_Genetics|Color|Academic_Department_of_Medical_Genetics,_University_of_Cambridge|Invitae|Counsyl|Mendelics|GeneDx|Center_for_Pediatric_Genomic_Medicine,Children's_Mercy_Hospital_and_Clinics|Athena_Diagnostics_Inc|CeGaT_Praxis_fuer_Humangenetik_Tuebingen|Fulgent_Genetics,Fulgent_Genetics|Integrated_Genetics/Laboratory_Corporation_of_America	Uncertain_significance|Uncertain_significance|Likely_pathogenic|Uncertain_significance|Uncertain_significance|Uncertain_significance|Uncertain_significance|Uncertain_Significance|Uncertain_significance|Uncertain_significance|Uncertain_significance|Uncertain_significance	2018-12-03|2018-09-11|2018-01-26|2018-12-23|2017-11-10|2018-07-02|2018-12-10|2016-01-18|2018-03-21|2018-09-01|2017-05-23|2019-07-10	2020-02-26|2018-11-06|2018-04-23|2019-03-28|2018-07-10|2018-08-20|2019-01-29|2016-05-19|2018-08-31|2019-07-12|2017-05-23|2019-09-24	criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter	germline|germline|germline|germline|unknown|unknown|germline|germline|germline|germline|unknown|germline	SCV000184428|SCV000537538|SCV000992202|SCV000218522|SCV000795616|SCV000838559|SCV000149126|SCV000280993|SCV000840946|SCV001148436|SCV000611367|SCV000918576	Hereditary_cancer-predisposing_syndrome|Hereditary_cancer-predisposing_syndrome|Hereditary_cancer-predisposing_syndrome|Ataxia-telangiectasia_syndrome|Ataxia-telangiectasia_syndrome|Ataxia-telangiectasia_syndrome|not_provided|not_provided|not_provided|not_provided|Familial_cancer_of_breast/Ataxia-telangiectasia_syndrome|not_specified	Insufficient_evidence||Application_of_AMCG_guidelines_2015._Used_other_ClinVar_submission_evidence_where_relevant._Loss_of_heterozygosity_in_tumours_or_immunohistochemistry_abnormalities_considered_functional_evidence_of_pathogenicity.|This_sequence_change_replaces_valine_with_leucine_at_codon_1941_of_the_ATM_protein_(p.Val1941Leu)._The_valine_residue_is_highly_conserved_and_there_is_a_small_physicochemical_difference_between_valine_and_leucine._This_variant_is_present_in_population_databases_(rs147187700,_ExAC_0.02%)._This_variant_has_been_reported_in_individuals_affected_with_breast_cancer_(PMID:_19781682,_16832357,_25503501),_chronic_lymphocytic_leukemia_(PMID:_21933854),_and_suspected_Lynch_syndrome_(PMID:_25980754)._However,_in_aÂ¬â€ large_meta-analysis_this_variant_was_not_associated_with_an_increased_risk_of_breast_cancer_(PMID:_19781682).Â¬â€ ClinVar_contains_an_entry_for_this_variant_(Variation_ID:_127412)._Experimental_studies_have_shown_that_this_missense_change_leads_to_reduced_ATM_kinase_activity_(PMID:_19431188)._In_summary,_the_available_evidence_is_currently_insufficient_to_determine_the_role_of_this_variant_in_disease._Therefore,_it_has_been_classified_as_a_Variant_of_Uncertain_Significance.|||This_variant_is_denoted_ATM_c.5821G>C_at_the_cDNA_level,_p.Val1941Leu_(V1941L)_at_the_protein_level,_and_results_in_the_change_of_a_Valine_to_a_Leucine_(GTT>CTT)._ATM_Val1941Leu_has_been_reported_in_individuals_with_breast_cancer,_glioma,_or_a_Lynch_related-cancer_and/or_polyps_undergoing_multigene_hereditary_cancer_testing_(Maxwell_2015,_Tung_2015,_Yurgelun_2015,_Zhang_2015,_Hauke_2018),_and_on_functional_interrogation,_demonstrated_reduced_ATM_protein_level_and_kinase_activity_(Barone_2009)._However,_in_two_large_case-control_studies_ATM_Val1941Leu_was_present_at_similar_or_lower_frequencies_in_breast_cancer_patients_compared_to_control_subjects_(Tavtigian_2009,_Decker_2017)._In_addition,_this_variant_was_present_at_similar_or_lower_frequencies_in_cases_vs._controls_in_two_chronic_lymphocytic_leukemia_case-control_studies_(Skowronska_2012,_Tiao_2017)._ATM_Val1941Leu_was_observed_at_an_allele_frequency_of_0.02%_(29/126,446)_in_individuals_of_European_ancestry_in_large_population_cohorts_(Lek_2016)._This_variant_is_not_located_in_a_known_functional_domain._In_silico_analysis,_which_includes_protein_predictors_and_evolutionary_conservation,_supports_that_this_variant_does_not_alter_protein_structure/function._Based_on_currently_available_evidence,_it_is_unclear_whether_ATM_Val1941Leu_is_a_pathogenic_or_benign_variant._We_consider_it_to_be_a_variant_of_uncertain_significance.|Converted_during_submission_to_Uncertain_significance.||||Variant_summary:_ATM_c.5821G>C_(p.Val1941Leu)_results_in_a_conservative_amino_acid_change_in_the_encoded_protein_sequence._Four_of_five_in-silico_tools_predict_a_benign_effect_of_the_variant_on_protein_function._The_variant_allele_was_found_at_a_frequency_of_0.00013_in_251056_control_chromosomes,_predominantly_at_a_frequency_of_0.00026_within_the_Non-Finnish_European_subpopulation_in_the_gnomAD_database._This_frequency_is_not_significantly_higher_than_expected_for_a_pathogenic_variant_in_ATM_causing_Breast_Cancer_(0.00013_vs_0.001),_allowing_no_conclusion_about_variant_significance._However,_the_variant_was_also_reported_in_10_/_9884_women_(i.e._with_a_frequency_of_about_0.001),_who_were_older_than_70_years_of_age,_and_never_had_cancer_(FLOSSIES_database),_which_might_suggest_a_benign_outcome_for_the_variant._c.5821G>C_has_been_reported_in_the_literature_in_individuals_affected_with_Breast_Cancer_(Shayeghi_1998,_Renwick_2006,_Maxwell_2015)_,_other_tumor_phenotypes_such_as_chronic_lymphocytic_leukemia_(CLL),_Lynch_syndrome-associated_cancer_and/or_polyps_,_pediatric_low_grade_glioma_(Skowronska_2011,_Yurgelun_2015,_Zhang_2015,_Tung_2015)_and_also_in_several_healthy_controls_(Skowronska_2011,_Tiao_2017,_Tavtigian_2009)._These_reports_therefore_do_not_provide_unequivocal_conclusions_about_association_of_the_variant_with_Breast_Cancer._Co-occurrence_with_another_pathogenic_variant_has_been_reported_for_this_variant_(BRCA1_c.3607C>T,_p.Arg1203X,_internal_sample),_which_further_supports_its_role_as_a_benign_variant._Using_an_ATM-null_lymphoblastoid_cell_line_(LCL)_transfected_with_the_variant_of_interest,_Barone_et_al_demonstrated_an_approximately_50%_decrease_in_protein_expression_(or_stability)_but_no_significant_decrease_in_specific_kinase_activity_(Barone_2009)._Nine_ClinVar_submissions_(evaluation_after_2014)_cite_the_variant_as_uncertain_significance._Based_on_the_evidence_outlined_above,_the_variant_was_classified_as_uncertain_significance.	TCGA_UCEC_328;TCGA_UCEC_328
NM_000038.5:c.6857C>T	APC	missense_variant	3&3	1&1	rs200587641	Hereditary cancer-predisposing syndrome&Familial adenomatous polyposis 1	127315	132772	Hereditary_cancer-predisposing_syndrome|Familial_adenomatous_polyposis_1|not_specified|Familial_adenomatous_polyposis|not_provided	-	MedGen:C0027672,SNOMED_CT:699346009|MedGen:C2713442,OMIM:175100|MedGen:CN169374|MedGen:CN240755|MedGen:CN517202	-	NC_000005.9:g.112178148C>T	_conflicting_interpretations	Conflicting_interpretations_of_pathogenicity	Benign(1),Likely_benign(4),Pathogenic(1),Uncertain_significance(3)	-	single_nucleotide_variant	SO:0001483	-	-	APC:324	SO:0001583|missense_variant	1	200587641	-	Sinai_Health_System|Invitae|Integrated_Genetics/Laboratory_Corporation_of_America	Likely_benign|Uncertain_significance|Likely_benign|not_provided|Likely_benign|Uncertain_significance|Uncertain_significance|Pathogenic|Benign|Likely_benign	2018-09-20|2018-08-01|2016-03-21|2013-09-19|2017-12-15|2018-03-27|2018-07-02|2015-11-20|2019-02-27|2017-01-19	2020-02-26|2018-08-08|2018-11-06|2014-05-29|2018-03-26|2018-06-20|2018-08-20|2017-10-30|2019-03-14|2018-01-25	criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|no_assertion_provided|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter	germline|germline|germline|germline|germline|unknown|unknown|germline|germline|germline	SCV000183908|SCV000821823|SCV000910682|SCV000084159|SCV000149025|SCV000786262|SCV000838144|SCV000591203|SCV000166053|SCV000694101	Hereditary_cancer-predisposing_syndrome|Hereditary_cancer-predisposing_syndrome|Hereditary_cancer-predisposing_syndrome|not_specified|not_specified|Familial_adenomatous_polyposis_1|Familial_adenomatous_polyposis_1|Familial_adenomatous_polyposis|not_provided|not_provided	Other_data_supporting_benign_classification:In_silico_models_in_agreement_(benign):Co-occurence_with_mutation_in_same_gene_(phase_unknown)||||This_variant_is_considered_likely_benign_or_benign_based_on_one_or_more_of_the_following_criteria:_it_is_a_conservative_change,_it_occurs_at_a_poorly_conserved_position_in_the_protein,_it_is_predicted_to_be_benign_by_multiple_in_silico_algorithms,_and/or_has_population_frequency_not_consistent_with_disease.|||||Variant_summary:_The_APC_c.6857C>T_(p.Ala2286Val)_variant_involves_the_alteration_of_a_non-conserved_nucleotide._2/4_in_silico_tools_predict_a_benign_outcome_for_this_variant_(SNPs&GO_not_captured_due_to_low_reliability_index)._This_variant_was_found_in_31/121008_control_chromosomes_(1_homozygote)_at_a_frequency_of_0.0002562,_which_is_approximately_4_times_the_estimated_maximal_expected_allele_frequency_of_a_pathogenic_APC_variant_(0.0000714),_suggesting_this_variant_is_likely_a_benign_polymorphism._This_variant_has_been_reported_in_one_individual_who_also_carries_a_potenially_pathogenic_APC_variant_(c.896_897delCT/p.Ser299CysfsX27,_UMD_database)._In_addition,_at_least_one_clinical_diagnostics_laboratory_classified_this_variant_as_likely_benign._Taken_together,_this_variant_is_classified_as_likely_benign.	TCGA_UCEC_347
NM_000179.2:c.3040_3042del	MSH6	inframe_deletion	-	-	-	-	89333	94807	Hereditary_nonpolyposis_colon_cancer|Hereditary_cancer-predisposing_syndrome|Hereditary_nonpolyposis_colorectal_cancer_type_5|not_provided	-	MedGen:C0009405,Orphanet:ORPHA443090|MedGen:C0027672,SNOMED_CT:699346009|MedGen:C1833477,OMIM:614350|MedGen:CN517202	-	NC_000002.11:g.48028159_48028161AAG[1]	_conflicting_interpretations	Conflicting_interpretations_of_pathogenicity	Uncertain_significance(5)	-	Microsatellite	SO:0000289	Quest_Diagnostics_Nichols_Institute_San_Juan_Capistrano:2698011|International_Society_for_Gastrointestinal_Hereditary_Tumours_(InSiGHT):c.3040_3042del	-	MSH6:2956	SO:0001822|inframe_deletion	1	267608073	-	Counsyl|Ambry_Genetics|Color|Invitae|GeneDx|Quest_Diagnostics_Nichols_Institute_San_Juan_Capistrano	Uncertain_significance|Likely_pathogenic|Uncertain_significance|Uncertain_significance|Uncertain_significance|Uncertain_significance	2016-09-29|2019-10-24|2018-09-06|2018-08-10|2018-05-10|2017-12-06	2016-11-23|2020-02-26|2018-11-06|2019-03-28|2019-01-29|2018-08-31	criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter	unknown|germline|germline|germline|germline|germline	SCV000489395|SCV000580309|SCV000690312|SCV000261496|SCV000565230|SCV000889479	Hereditary_nonpolyposis_colorectal_cancer_type_5|Hereditary_cancer-predisposing_syndrome|Hereditary_cancer-predisposing_syndrome|Hereditary_nonpolyposis_colon_cancer|not_provided|not_provided	|Detected_in_individual_satisfying_established_diagnostic_critera_for_classic_disease_without_a_clear_mutation:Rarity_in_general_population_databases_(dbsnp,_esp,_1000_genomes):Structural_Evidence:Other_data_supporting_pathogenic_classification||This_sequence_change_deletes_3_nucleotides_from_exon_4_of_the_MSH6_mRNA_(c.3040_3042delAAG)._This_leads_to_the_deletion_of_1_amino_acid_residue_in_the_MSH6_protein_(p.Lys1014del)_but_otherwise_preserves_the_integrity_of_the_reading_frame._While_this_variant_is_present_in_population_databases_(rs753885956),_the_frequency_information_is_unreliable,_as_metrics_indicate_poor_data_quality_at_this_position_in_the_ExAC_database._This_variant_has_been_reported_in_individuals_affected_with_colon,_endometrial,_and_pancreatic_cancer_(PMID:_12658575,_18301448,_26483394)._This_variant_is_also_known_as_1013delCTT_and_c.3037_3039delAAG,_p.Lys1013del_in_the_literature._ClinVar_contains_an_entry_for_this_variant_(Variation_ID:_89333)._Experimental_studies_and_prediction_algorithms_are_not_available_for_this_variant,_and_the_functional_significance_of_the_deleted_amino_acid_is_currently_unknown._In_summary,_the_available_evidence_is_currently_insufficient_to_determine_the_role_of_this_variant_in_disease._Therefore,_it_has_been_classified_as_a_Variant_of_Uncertain_Significance.|This_in-frame_deletion_of_3_nucleotides_in_MSH6_is_denoted_c.3040_3042delAAG_at_the_cDNA_level_and_p.Lys1014del_(K1014del)_at_the_protein_level._The_normal_sequence,_with_the_bases_that_are_deleted_in_brackets,_is_AAAG[delAAG]TTGG._This_variant,_also_reported_as_c.3037_3039delAAG,_p.Lys1013del_and_1013delTTC,_has_been_observed_in_at_least_three_individuals_with_a_history_of_a_Lynch_syndrome_related_cancer:_tumor_testing_on_one_of_these_individual?s_colon_tumor_showed_that_it_was_MSI-H_with_loss_of_MSH2_and_MSH6_via_MMR_IHC_(Wagner_2003,_Steinke_2008,_Hu_2015)._This_variant_was_not_observed_at_a_significant_allele_frequency_in_large_population_cohorts_(Lek_2016)._This_deletion_of_a_single_Lysine_residue_is_located_in_the_lever_domain_(Warren_2007,_Kansikas_2011)._In_silico_analysis,_which_includes_protein_predictors_and_evolutionary_conservation,_supports_a_deleterious_effect._Since_in-frame_deletions_may_or_may_not_inhibit_proper_protein_functioning,_the_clinical_significance_of_this_finding_remains_unclear_at_this_time_and_we_consider_MSH6_Lys1014del_to_be_a_variant_of_uncertain_significance.|	TCGA_UCEC_393
NM_001128425.1:c.700G>A	MUTYH	missense_variant	-	-	-	-	135989	139701	Hereditary_cancer-predisposing_syndrome|MYH-associated_polyposis|not_specified|not_provided	-	MedGen:C0027672,SNOMED_CT:699346009|MedGen:C1837991,OMIM:608456,Orphanet:ORPHA247798|MedGen:CN169374|MedGen:CN517202	-	NC_000001.10:g.45798151C>T	_conflicting_interpretations	Conflicting_interpretations_of_pathogenicity	Uncertain_significance(11)	-	single_nucleotide_variant	SO:0001483	ARUP_Laboratories,_Molecular_Genetics_and_Genomics,_ARUP_Laboratories:1204684	-	MUTYH:4595	SO:0001619|non-coding_transcript_variant	1	200165598	-	Invitae|Counsyl|University_of_Washington_Department_of_Laboratory_Medicine,_University_of_Washington|Ambry_Genetics|Color|Quest_Diagnostics_Nichols_Institute_San_Juan_Capistrano|Laboratory_for_Molecular_Medicine,_Partners_HealthCare_Personalized_Medicine|ARUP_Laboratories,_Molecular_Genetics_and_Genomics,_ARUP_Laboratories|GeneDx|Integrated_Genetics/Laboratory_Corporation_of_America|PreventionGenetics,PreventionGenetics|Quest_Diagnostics_Nichols_Institute_San_Juan_Capistrano	Uncertain_significance|Uncertain_significance|Likely_pathogenic|Uncertain_significance|Uncertain_significance|Uncertain_significance|Uncertain_significance|Uncertain_significance|Uncertain_significance|Uncertain_significance|Uncertain_significance|Uncertain_significance	2018-12-28|2015-11-18|2018-02-16|2019-02-08|2018-06-07|2017-03-18|2017-01-11|2019-05-04|2018-07-31|2016-12-05|2017-07-25|2017-03-18	2019-03-28|2016-11-23|2018-11-05|2020-02-26|2018-11-06|2017-08-01|2019-03-21|2019-08-05|2019-01-29|2018-01-25|2018-01-29|2018-08-31	criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter|criteria_provided,_single_submitter	germline|unknown|germline|germline|germline|germline|germline|germline|germline|germline|germline|germline	SCV000166457|SCV000487314|SCV000788256|SCV000186820|SCV000685660|SCV000601657|SCV000712773|SCV001159672|SCV000211403|SCV000697707|SCV000806366|SCV000889534	MYH-associated_polyposis|MYH-associated_polyposis|MYH-associated_polyposis|Hereditary_cancer-predisposing_syndrome|Hereditary_cancer-predisposing_syndrome|not_specified|not_specified|not_specified|not_provided|not_provided|not_provided|not_provided	This_sequence_change_replaces_valine_with_methionine_at_codon_234_of_the_MUTYH_protein_(p.Val234Met)._The_valine_residue_is_highly_conserved_and_there_is_a_small_physicochemical_difference_between_valine_and_methionine._This_variant_is_present_in_population_databases_(rs200165598,_ExAC_0.02%)._This_variant_has_been_reported_in_individuals_and_families_affected_with_colon_cancer_(PMID:_16774938,_14991577)._This_variant_is_also_known_as_c.658G>A_(p.Val220Met)_in_the_literature._ClinVar_contains_an_entry_for_this_variant_(Variation_ID:_135989)._Experimental_studies_have_shown_that_this_missense_change_partially_impairs_MUTYH_protein_function_(PMID:_25820570,_26694661)._The_clinical_significance_of_this_finding_is_unknown._In_summary,_the_available_evidence_is_currently_insufficient_to_determine_the_role_of_this_variant_in_disease._Therefore,_it_has_been_classified_as_a_Variant_of_Uncertain_Significance.||The_MUTYH_variant_designated_as_NM_001128425.1:c.700G>A_(p.Val234Met)_is_classified_as_likely_pathogenic._In_one_observed_family,_this_variant_co-occurs_with_a_known_pathogenic_variant_(MUTYH_p.Tyr179Cys_or_p.Y179C)_in_MUTYH_in_five_siblings_who_each_have_a_documented_history_of_multiple_colon_polyps_and/or_colon_cancer._The_variant_was_shown_to_be_in_trans_configuration_with_the_MUTYH_p.Y179C_variant._This_genomic_position_is_highly_conserved._Experimental_studies_of_this_variant_have_shown_that_it_partially_impairs_MUTYH_protein_function_(Komine_2015,_PMID:_25820570)._This_variant_is_listed_in_population_databases_and_is_present_in_1/5500_individuals_of_European_descent_(exac.broadinstitute.org)._Bayesian_analysis_integrating_all_of_this_data_(Tavtigian_et_al,_2018)_gives_about_98%_probability_of_pathogenicity,_which_is_consistent_with_a_classification_of_likely_pathogenic._MUTYH_p.Val234Met_is_expected_to_alter_MUTYH_function_and_increase_the_risk_of_developing_colon_cancer,_multiple_colon_polyps,_and_other_features_of_MYH-associated_polyposis_when_it_co-occurs_with_a_pathogenic_mutation_in_MUTYH_(Morak_2010,_PMID_20618354:_Grover_2012,_PMID:_22851115)._This_analysis_was_performed_in_conjunction_with_the_family_studies_project_as_part_of_the_University_of_Washington_Find_My_Variant_Study.|Insufficient_or_conflicting_evidence|||The_p.Val234Met_variant_in_MUTYH_has_been_reported_in_2_individuals_with_colorec_tal_cancer_(Fleischmann_2004,_Peterlongo_2006)._In_vitro_functional_studies_are_contradictory_with_one_study_providing_evidence_that_the_p.Val234Met_variant_may_impact_protein_function_(Komine_2015),_while_another_study_showed_that_the_prot_ein_function_is_fully_retained_(Shinmura_2016)._However,_these_types_of_assays_m_ay_not_accurately_represent_biological_function._This_variant_has_been_identifie_d_in_15/65590_European_chromosomes_by_the_Exome_Aggregation_Consortium_(ExAC,_ht_tp://exac.broadinstitute.org:_dbSNP_rs200165598)._Computational_prediction_tools_and_conservation_analysis_do_not_provide_strong_support_for_or_against_an_impac_t_to_the_protein._In_summary,_the_clinical_significance_of_the_p.Val234Met_varia_nt_is_uncertain.|The_MUTYH_c.700G>A:_p.Val234Met_variant_(rs200165598),_also_known_as_Val220Met_for_traditional_nomenclature,_is_reported_in_the_literature_in_individuals_with_colorectal_cancer_but_a_second_MUTYH_variant_was_not_identified_(Fleischmann_2004,_Peterlongo_2006,_Yurgelun_2015)._Our_laboratory_has_identified_this_variant_previously_in_an_individual_with_a_personal_and_family_history_of_colon_cancer,_who_also_carried_a_pathogenic_MUTYH_frameshift_variant._One_functional_study_shows_that_the_p.Val234Met_variant_protein_has_partially_defective_function_(Komine_2015),_while_another_study_shows_the_variant_protein_retains_normal_repair_activity_(Shinmura_2016)._This_variant_is_reported_in_ClinVar_(Variation_ID:_135989)._It_is_found_in_the_general_European_(non-Finnish)_population_with_an_allele_frequency_of_0.02%_(23/128662_alleles)_in_the_Genome_Aggregation_Database._Due_to_limited_information,_the_significance_of_this_variant_is_uncertain_at_this_time._REFERENCES_Fleischmann_C_et_al._Comprehensive_analysis_of_the_contribution_of_germline_MYH_variation_to_early-onset_colorectal_cancer._Int_J_Cancer._2004_Apr_20:109(4):554-8._Komine_K_et_al._Functional_Complementation_Assay_for_47_MUTYH_Variants_in_a_MutY-Disrupted_Escherichia_coli_Strain._Hum_Mutat._2015_Jul:36(7):704-11._Peterlongo_P_et_al._Increased_frequency_of_disease-causing_MYH_mutations_in_colon_cancer_families._Carcinogenesis._2006_Nov:27(11):2243-9._Shinmura_K_et_al._Functional_Evaluation_of_Nine_Missense-Type_Variants_of_the_Human_DNA_Glycosylase_Enzyme_MUTYH_in_the_Japanese_Population._Hum_Mutat._2016_Apr:37(4):350-3._Yurgelun_MB_et_al._Identification_of_a_Variety_of_Mutations_in_Cancer_Predisposition_Genes_in_Patients_With_Suspected_Lynch_Syndrome._Gastroenterology._2015_Sep:149(3):604-13.e20.|This_variant_is_denoted_MUTYH_c.700G>A_at_the_cDNA_level,_p.Val234Met_(V234M)_at_the_protein_level,_and_results_in_the_change_of_a_Valine_to_a_Methionine_(GTG>ATG)._MUTYH_Val234Met,_previously_reported_as_c.658G>A,_Val220Met,_and_Val206Met_using_alternate_transcripts,_has_been_reported_in_individuals_diagnosed_with_colon_cancer_as_well_as_in_healthy_controls_(Fleischmann_2004,_Peterlongo_2006,_DeRycke_2017)._While_Komine_et_al._(2015)_showed_MUTYH_Val234Met_to_have_partially_defective_base_excision_repair_activity_in_an_E._coli-based_complementation_assay,_Shinmura_et_al._(2015)_reported_this_variant_to_have_almost_fully_retained_DNA_glycosylase_activity_in_vitro_and_mutation_suppression_ability_similar_to_wild-type_in_a_human_cell_line._MUTYH_Val234Met_was_observed_at_an_allele_frequency_of_0.02%_(24/126,336)_in_individuals_of_European_ancestry_in_large_population_cohorts_(Lek_2016)._This_variant_is_located_in_the_MSH6_binding_domain_(Gu_2002,_Ruggieri_2013)._While_protein-based_in-silico_analysis_supports_that_this_variant_does_not_alter_protein_structure/function,_multiple_splicing_based_in-silico_models_predict_that_this_variant_may_create_a_cryptic_splice_donor_site_upstream_of_the_nearby_natural_splice_donor_site._However,_in_the_absence_of_RNA_or_functional_studies,_the_actual_effect_of_this_variant_on_splicing_is_unknown._Based_on_currently_available_evidence,_it_is_unclear_whether_MUTYH_Val234Met_is_a_pathogenic_or_benign_variant._We_consider_it_to_be_a_variant_of_uncertain_significance._Of_note,_MUTYH-Associated_Polyposis_(MAP)_is_a_recessive_condition_associated_with_two_MUTYH_pathogenic_variants_on_opposite_chromosomes.|||	TCGA_UCEC_436
